非透析依赖型慢性肾脏病中的贫血：治疗还是不治疗？ - Suppr

Suppr

超能文献

Anemia in Non-Dialysis-Dependent CKD: To Treat or Not to Treat?

作者信息

Fishbane Steven, Ross Daniel W, Hong Susana

机构信息

Division of Nephrology, Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.

出版信息

Am J Kidney Dis. 2019 Mar;73(3):297-299. doi: 10.1053/j.ajkd.2018.11.006. Epub 2019 Jan 5.

DOI:10.1053/j.ajkd.2018.11.006

PMID:30616872

Abstract

摘要

相似文献

Anemia in Non-Dialysis-Dependent CKD: To Treat or Not to Treat?非透析依赖型慢性肾脏病中的贫血：治疗还是不治疗？

Am J Kidney Dis. 2019 Mar;73(3):297-299. doi: 10.1053/j.ajkd.2018.11.006. Epub 2019 Jan 5.

Initiation of darbepoetin for management of anemia in non-dialysis-dependent patients with chronic kidney disease.使用达比加群酯治疗非透析依赖型慢性肾脏病患者的贫血。

Saudi J Kidney Dis Transpl. 2016 Nov-Dec;27(6):1182-1187. doi: 10.4103/1319-2442.194607.

Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.贫血、CKD 和 2 型糖尿病患者的血红蛋白稳定性：阿法依泊汀治疗（TREAT）安慰剂臂分析。

Am J Kidney Dis. 2013 Feb;61(2):238-46. doi: 10.1053/j.ajkd.2012.08.043. Epub 2012 Nov 16.

Darbepoetin Alfa Versus Erythropoietin Alfa for Treatment of Renal Anemia in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage: A Randomized Non-inferiority Trial.达比泊汀α与促红细胞生成素α治疗慢性肾脏病透析前阶段患者肾性贫血的随机非劣效性试验。

J Assoc Physicians India. 2019 Jan;67(1):62-66.

Anemia Treatment by Erythropoiesis-stimulating Agents during the 6 Months before the Initiation of Hemodialysis: Comparison of Darbepoetin Alfa and Continuous Erythropoietin Receptor Activator.血液透析开始前6个月使用促红细胞生成剂治疗贫血：达贝泊汀α与持续促红细胞生成素受体激活剂的比较

Keio J Med. 2017 Sep 26;66(3):44-50. doi: 10.2302/kjm.2016-0009-OA. Epub 2016 Dec 19.

De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease.新诊断慢性肾脏病患儿每周和每两周一次皮下注射达贝泊汀的疗效。

Pediatr Nephrol. 2018 Jan;33(1):125-137. doi: 10.1007/s00467-017-3758-5. Epub 2017 Aug 17.

Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).一项随机对照试验的原理与研究设计，该试验旨在评估使用阿法依泊汀维持血红蛋白水平对预防非糖尿病慢性肾脏病患者终末期肾病发生的影响（PREDICT试验）。

Clin Exp Nephrol. 2016 Feb;20(1):71-6. doi: 10.1007/s10157-015-1133-z. Epub 2015 Jun 17.

Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study.达贝泊汀α在慢性肾病儿童中的安全性及应用：前瞻性注册研究

Pediatr Nephrol. 2016 Mar;31(3):443-53. doi: 10.1007/s00467-015-3225-0. Epub 2015 Oct 19.

Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.非透析慢性肾病患者长期使用阿法达贝泊汀的安全性和有效性：日本一项上市后监测研究

Clin Exp Nephrol. 2019 Feb;23(2):231-243. doi: 10.1007/s10157-018-1632-9. Epub 2018 Sep 4.

Anemia treatment in patients with chronic kidney disease.慢性肾脏病患者的贫血治疗

N Engl J Med. 2013 Jan 24;368(4):387-9. doi: 10.1056/NEJMe1215043.

引用本文的文献

Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease.小鼠中促红细胞生成素的转基因增强改善了腺嘌呤诱导的慢性肾病中的贫血。

bioRxiv. 2024 Dec 10:2024.12.06.627111. doi: 10.1101/2024.12.06.627111.

Prevalence, incidence, and treatment of anaemia in patients with non-dialysis-dependent chronic kidney disease: findings from a retrospective real-world study in Italy.意大利一项回顾性真实世界研究显示：非透析依赖性慢性肾脏病患者的贫血患病率、发病率和治疗情况。

J Nephrol. 2023 Mar;36(2):347-357. doi: 10.1007/s40620-022-01475-x. Epub 2022 Nov 12.

Epidemiology and outcomes in patients with anemia of CKD not on dialysis from a large US healthcare system database: a retrospective observational study.从大型美国医疗保健系统数据库中观察透析不充分的慢性肾脏病贫血患者的流行病学和结局：一项回顾性观察研究。

BMC Nephrol. 2022 Apr 30;23(1):166. doi: 10.1186/s12882-022-02778-8.

Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat.慢性肾脏病贫血患者的安全有效治疗：关于罗沙司他的最新系统评价和荟萃分析

Front Pharmacol. 2021 Jul 2;12:658079. doi: 10.3389/fphar.2021.658079. eCollection 2021.

Low serum iron is associated with anemia in CKD stage 1-4 patients with normal transferrin saturations.低血清铁与 CKD 1-4 期且转铁蛋白饱和度正常患者的贫血相关。

Sci Rep. 2021 Apr 16;11(1):8343. doi: 10.1038/s41598-021-87401-w.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验